Real-world treatment pathways and outcomes in metastatic NSCLC across Spanish hospitals: Insights from the ECO-ARWEN study.
716 Background: Real-world evidence can help evaluate whether advances in oncology care are being consistently translated into routine clinical practice. The rapid evolution of immunotherapy and targeted therapies has reshaped the management of metastatic non-small cell lung cancer (mNSCLC). However, the extent...